Agios Pharmaceuticals, Inc.
AGIO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1,867 | $1,239 | $1,538 | $1,987 |
| - Cash | $76 | $88 | $139 | $203 |
| + Debt | $57 | $72 | $86 | $97 |
| Enterprise Value | $1,847 | $1,223 | $1,485 | $1,881 |
| Revenue | $36 | $27 | $14 | $0 |
| % Growth | 36.1% | 88.4% | – | – |
| Gross Profit | $32 | $17 | $13 | -$19 |
| % Margin | 88.6% | 64.6% | 88% | – |
| EBITDA | -$420 | -$385 | -$380 | -$338 |
| % Margin | -1,151% | -1,434.8% | -2,671.9% | – |
| Net Income | $674 | -$352 | -$232 | $1,605 |
| % Margin | 1,845.9% | -1,312.6% | -1,627.8% | – |
| EPS Diluted | 11.64 | -6.33 | -4.23 | -6.36 |
| % Growth | 283.9% | -49.6% | 33.5% | – |
| Operating Cash Flow | -$390 | -$296 | -$309 | -$407 |
| Capital Expenditures | -$2 | -$1 | -$5 | -$6 |
| Free Cash Flow | -$392 | -$297 | -$314 | -$413 |